Speaker illustration

Associate Professor Emil Hagstrom

Uppsala University, Uppsala (Sweden)

Member of:

European Society of Cardiology

Risk factor control and long-term outcomes after myocardial infarction

Event: ESC Congress 2019

Topic: Prevention

Session: Late Breaking Science in Prevention 2


Cost-effectiveness of evolocumab in patients with high atherosclerotic cardiovascular risk in Sweden

Event: ESC Congress 2019

Topic: Drug therapy

Session: How good/bad are we in treating lipids


ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb